SCYNEXIS Files 8-K for Regulation FD and Exhibits

Ticker: SCYX · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1178253

Scynexis Inc 8-K Filing Summary
FieldDetail
CompanyScynexis Inc (SCYX)
Form Type8-K
Filed DateSep 10, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K

Related Tickers: SCYX

TL;DR

SCYNEXIS filed a routine 8-K, no new material news.

AI Summary

SCYNEXIS, Inc. filed an 8-K on September 10, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not contain specific details about new financial events or material disclosures beyond its procedural nature.

Why It Matters

This 8-K filing indicates SCYNEXIS is adhering to regulatory reporting requirements, but it does not disclose new material information that would immediately impact its stock price.

Risk Assessment

Risk Level: low — The filing is a standard procedural report and does not contain any new material information or events that would inherently increase risk.

Key Players & Entities

  • SCYNEXIS, Inc. (company) — Registrant
  • September 10, 2024 (date) — Date of earliest event reported
  • Regulation FD (regulation) — Disclosure item
  • 1 Evertrust Plaza 13th Floor (address) — Principal Executive Offices
  • Jersey City, New Jersey (location) — Principal Executive Offices location
  • 07302-6548 (zip_code) — Principal Executive Offices zip code
  • 201 884-5485 (phone_number) — Registrant's Telephone Number

FAQ

What is the primary purpose of this 8-K filing by SCYNEXIS, Inc.?

The primary purpose of this 8-K filing is to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on September 10, 2024.

What is SCYNEXIS, Inc.'s principal executive office address?

SCYNEXIS, Inc.'s principal executive office is located at 1 Evertrust Plaza, 13th Floor, Jersey City, New Jersey, 07302-6548.

What is the telephone number for SCYNEXIS, Inc. as listed in the filing?

The telephone number for SCYNEXIS, Inc. is 201 884-5485.

Does this 8-K filing disclose any new material events or financial updates for SCYNEXIS, Inc.?

Based on the provided text, this 8-K filing appears to be procedural, covering Regulation FD disclosures and exhibits, without detailing specific new material events or financial updates.

Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-09-10 08:01:19

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share SCYX The Nasdaq Global Ma

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 10, 2024, SCYNEXIS, Inc. (the "Company") updated its investor slide presentation ("Corporate Presentation"). The Corporate Presentation is available on the Company's website and is furnished as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 hereto are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation 100 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCYNEXIS, Inc. Date: September 9, 2024 By: /s/ David Angulo, M.D. Name: David Angulo, M.D. Its: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.